How to Reduce Florida’s Drug-Related Illnesses and Deaths: “You Cannot Arrest Your Way Out of this Problem"

Sheriff Dennis Lemma and Scott Tucker sxs headshots
Dennis Lemma, Seminole County Sheriff (left) and Scott Tucker, Ph.D., AdventHealth’s Hope & Healing Center clinical director of operations (right)

In this episode of the Inspiring Wholeness podcast, Seminole County Sheriff Dennis Lemma joins Scott Tucker, Ph.D., clinical director of operations for AdventHealth Hope & Healing Center, to discuss how the substance abuse treatment center is making an impact on drug-related illnesses and deaths and reshaping the narrative around these mental health disorders.

“The only way to address this is in the medical space. You cannot arrest your way out of this problem,” Lemma said. “Up until this point, many people would receive adequate health care services in separate spaces. Finding a convenient, holistic way to do that was incredibly important.”

Listen now and subscribe so you never miss a new episode.

Recent News

12 items. To interact with these items, press Control-Option-Shift-Right Arrow. These items are in a slider. To advance slider forward, press Shift-Command-Right Arrow. To advance slider backward, press Shift-Command-Left Arrow.
News
AdventHealth Neuroscience Institute Among First in U.S. to Offer Phase IIa Clinical Trial of Troculeucel for Moderate Alzheimer’s Disease

While most clinical trials for Alzheimer’s disease have focused on patients with early or mild cognitive impairment, roughly 30% of those with Alzheimer’s have moderate stage disease for which there...

Read Article about "AdventHealth Neuroscience Institute Among First in U.S. to Offer Phase IIa Clinical Trial of Troculeucel for Moderate Alzheimer’s Disease "
News
AdventHealth Translational Research Institute Selected as Clinical Site for National Study of Muscle, Mobility and Aging (SOMMA)

Under the leadership of Scientific Director and Principal Investigator Bret H. Goodpaster, PhD, the AdventHealth Translational Research Institute (TRI) is now enrolling men and women 70 years of age...

Read Article about "AdventHealth Translational Research Institute Selected as Clinical Site for National Study of Muscle, Mobility and Aging (SOMMA) "
News
AdventHealth Neuroscience Institute Administers First Dose of Investigative NK Cell Therapy to Person with Alzheimer’s Disease

Under a single compassionate use Investigational New Drug (IND) authorization cleared by the U.S. Food and Drug Administration (FDA), the AdventHealth Neuroscience Institute worked with NKGen Biotech...

Read Article about "AdventHealth Neuroscience Institute Administers First Dose of Investigative NK Cell Therapy to Person with Alzheimer’s Disease "
View More Articles